MSD Partners’s Halozyme HALO Stock Holding History

MSD Partners’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,245,000	Closed	-$40.8M	–	29
2018 Q3	$40.8M	Hold	2,245,000	–	–	3.07%	10
2018 Q2	$37.9M	Hold	2,245,000	–	–	1.62%	11
2018 Q1	$44M	Hold	2,245,000	–	–	2.23%	7
2017 Q4	$45.5M	Hold	2,245,000	–	–	2.36%	4
2017 Q3	$39M	Hold	2,245,000	–	–	1.14%	10
2017 Q2	$28.8M	Buy	2,245,000 +1,480,000	+193%	+$19.8M	1.79%	15
2017 Q1	$9.91M	Sell	765,000 -200,000	-21%	-$2.53M	0.49%	21
2016 Q4	$9.53M	Hold	965,000	–	–	0.48%	22
2016 Q3	$11.7M	Hold	965,000	–	–	0.94%	23
2016 Q2	$8.33M	Buy	965,000 +45,000	+5%	+$444K	0.54%	39
2016 Q1	$8.71M	Buy	+920,000	New	+$8.66M	0.46%	39

Other funds holding HALO

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

MSD Partners's HALO Position: Q4 2018 in Review

MSD Partners sold out of Halozyme (HALO) in Q4 2018, closing a stake of 2,245,000 shares — an estimated $40.8M sold.

MSD Partners first reported a position in HALO in Q1 2016 and held it in 11 quarters. The position peaked at $45.5M in Q4 2017. 195 funds tracked by Wall St. Rank hold HALO as of Q4 2018.

MSD Partners reported no remaining Halozyme position as of Q4 2018 after selling out during the quarter.
MSD Partners sold 2,245,000 Halozyme shares in Q4 2018, an estimated $40.8M.
MSD Partners first reported a position in Halozyme in Q1 2016 and held it in 11 quarters.
MSD Partners's Halozyme position peaked at $45.5M in Q4 2017.
195 funds tracked by Wall St. Rank held Halozyme as of Q4 2018.

Based on MSD Partners's 13F filing for Q4 2018, filed 14 Feb 2019.